北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (4): 630-633.doi: 10.3969/j.issn.1671-167X.2018.04.010

• 论著 • 上一篇    下一篇

单中心16年青年膀胱尿路上皮癌患者的诊治

唐兴国1*#,颜野1*,邱敏1△,卢剑1,陆敏2,侯小飞1,黄毅1,马潞林1   

  1. (北京大学第三医院1.泌尿外科, 2.病理科, 北京100191)
  • 出版日期:2018-08-18 发布日期:2018-08-18
  • 通讯作者: 邱敏 E-mail:qm1868@sina.com

Retrospective study of young bladder urothelial carcinoma from a single center within 16 years

TANG Xing-guo1*#, YAN Ye1*, QIU Min1△, LU Jian1, LU Min2, HOU Xiao-fei1, HUANG Yi1, MA Lu-lin1   

  1. (1. Department of Urology, 2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2018-08-18 Published:2018-08-18
  • Contact: QIU Min E-mail:qm1868@sina.com

摘要: 目的:研究40岁及以下青年膀胱尿路上皮癌患者的临床表现、临床分期、病理分级、治疗及预后等情况。方法:选择 2001年1月至2016年12月北京大学第三医院泌尿外科收治的43例40岁及以下的膀胱癌患者临床资料进行回顾性分析。结果:本组病例占同期科室收治的膀胱癌患者的2.2%,男性35例,女性8例,平均年龄33岁(23~40岁)。初诊时以无痛性肉眼血尿为主要症状者27例(62.8%), 体检发现异常者9例(20.9%),以膀胱刺激症状或排尿异常起病者7例(16.3%)。肿瘤单发者34例(79.1%),多发者9例(20.9%),且多发者均在31~40岁亚组。根据患者临床分期采用相应的手术方式治疗。 术后病理分级:低级别乳头状尿路上皮癌29例(67.4%),高级别乳头状尿路上皮癌14例(32.6%)。Ta期31例(72.1%),T1期7例(16.3%), T3期1例(2.3%), T4期3例(7.0%),T1期合并Tis 1例(2.3%)。术后3例失访,另40例随访5~165个月,随访患者中有5例复发,复发率12.5%(5/40), 平均复发时间39个月(3~105个月), 2例患者进展,进展率5%(2/40)。多发患者组复发率33%(3/9),单发患者组复发率5.9%(2/34),两组差异具有统计学意义(P=0.000 3)。结论:青年膀胱癌的发病比例呈增长趋势, 无痛性肉眼血尿是青年膀胱癌的主要临床表现,但青年患者的下尿路刺激症状同样需警惕肿瘤的发生,术后的复发情况可能与多发病变有关。

关键词:  , 膀胱癌, 青年, 预后

Abstract: Objective: To evaluate the clinical and pathological features, treatment and prognosis for bladder urothelial carcinoma in relative young patients under 40 years. Methods: A retrospective study involved a total of 43 consecutive patients of bladder urothelial carcinoma, which were under 40 years old from January 2001 to December 2016. Results: The incidence rate of bladder urothelial carcinoma in the patients under 40 years was 2.2%, and 35 males and 8 females were included. The average age was 33 years (ranging from 23 to 40 years). At initial visit, 62.8% of the patients presented with painless gross hematuria, 9 patients were discovered by routine examination, and 7 patients experienced lower urinary tract symptoms. Solitary tumor occurred in 34 cases whereas multiple carcinomas had been discovered in 9 cases,and all the 9 multiple cases were from 31-40-year-old subgroups. All the patients received proper surgical intervention according to their own clinical stages. Post-operative pathological results showed 29 low-grade urothelial carcinoma and 14 high-grade cases which included 31 Ta cases, with 7 cases of T1, 1 case of T3, and 3 cases of T4 and one case of T1 plus Tis. The total follow-up was from 5 to 165 months,3 cases were lost. The overall recurrence rate was 12.5% (5 cases from 40). One patient developed distal metastasis, one died of metastasis after 13 months, and the other three received secondary trans-urethral resection of bladder tumors. The average recurrence time was 39 months (rang-ing from 3 to 105 months). The progression rate was 5% among all the followedup patients (2 cases from 40). The recurrence rate in multiple lesions group (33%, 3/9) was significantly higher than that (5.9%, 2/34) in solitary lesion group (P=0.000 3). Conclusion: The incidence rate of bladder urothelial carcinoma in young patients under 40 years becomes increasingly higher over years. The major initial presentation is painless gross hematuria among these young patients, but lower urinary tract symptoms should also be noticed for young patients to rule out tumor. Postoperative tumor recurrence might be associated with multiple lesions, which is not related to the tumor size or pathological features.

Key words: Bladder urothelial carcinoma, Young, Prognosis

中图分类号: 

  • R694
[1] 李胜光,张清,周惠琼. 抗中性粒细胞胞质抗体相关性血管炎的病情评估方法及其相关性[J]. 北京大学学报(医学版), 2018, 50(6): 1022-1026.
[2] 丁艳苓,沈宁,周庆涛,贺蓓,郑佳佳,赵心懋. 非免疫缺陷宿主念珠菌血流感染[J]. 北京大学学报(医学版), 2018, 50(6): 1063-1069.
[3] 李刚,王健生,秦思达,张佳,杜宁,张靖,孙欣,任宏. 布地奈德联合氨溴索氧化驱动雾化吸入预防成人开胸术后肺炎的临床疗效[J]. 北京大学学报(医学版), 2018, 50(5): 840-844.
[4] 倪莲芳,王鹤,李虹,张志刚,刘新民. 非人类免疫缺陷病毒感染肺隐球菌病34例临床分析[J]. 北京大学学报(医学版), 2018, 50(5): 855-860.
[5] 王芳芳,杨殷杰,侯晓玫. 电火花蚀刻镍钛根管锉HyFlex EDM的表面形态和抗疲劳折断性能[J]. 北京大学学报(医学版), 2018, 50(5): 876-881.
[6] 王昊,陈亮,叶小云. 雷公藤甲素对TM4细胞氧化应激及PI3K/AKT通路的影响[J]. 北京大学学报(医学版), 2018, 50(4): 607-612.
[7] 王建伟,满立波,黄广林,王海,徐啸,朱晓斐,李玮,刘振华. 经会阴三步法手术策略治疗单纯性男性骨盆骨折后尿道离断[J]. 北京大学学报(医学版), 2018, 50(4): 617-620.
[8] 吴恺,张杨,张红,檀增桓,郭晓蕙,杨建梅. 嗜铬细胞瘤/副神经节瘤患者RET、VHL、SDHD、SDHB遗传基因变异的检测[J]. 北京大学学报(医学版), 2018, 50(4): 634-639.
[9] 吴鹏辉,谢瑶,赵卫红,华瑛,孙青,李硕,吴晔,卢新天. 血液病/肿瘤患儿并发可逆性后部白质脑病综合征[J]. 北京大学学报(医学版), 2018, 50(4): 662-665.
[10] 徐奔,张喆楠,罗程,宋海峰,张骞. 后腹腔镜下肿瘤吸除术与肾部分切除术治疗肾血管平滑肌脂肪瘤的安全性与有效性对比[J]. 北京大学学报(医学版), 2018, 50(4): 700-704.
[11] 郝一昌,侯小飞,赵磊,肖春雷,刘茁,张帆,马潞林. 全腹腔镜移植输尿管膀胱再植术处理肾移植术后输尿管狭窄[J]. 北京大学学报(医学版), 2018, 50(4): 705-710.
[12] 覃子健,毕海,马潞林,黄毅,张帆. 肠代膀胱内原发肠源性腺癌1例[J]. 北京大学学报(医学版), 2018, 50(4): 737-739.
[13] 朱冬冬,朱军,虞巍,王冰洁,陈宇珂,范宇,张中元,金杰,谌诚. 双侧睾丸肿瘤12例报道及文献回顾[J]. 北京大学学报(医学版), 2018, 50(4): 755-758.
[14] 张慧峰,黄焕焕,赵雨佳,李清如,祁宇泽,周辉. 苯并[a]芘对神经胶质细胞中胰岛素降解酶与脑啡肽酶表达的影响[J]. 北京大学学报(医学版), 2018, 50(3): 401-407.
[15] 林鸿波,陈奕,沈鹏,李小勇,司亚琴,张杜丹,唐迅,高培. 社区糖尿病患者慢性肾脏病的发病率及其危险因素[J]. 北京大学学报(医学版), 2018, 50(3): 416-421.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 杜绍财, 张瑞, 李俊强, 魏来. 尿苷酶在丙型肝炎病毒逆转录-抗污染-联体聚合酶链反应中的应用[J]. 北京大学学报(医学版), 2007, 39(4): 426 -428 .
[2] 钟金晟, 欧阳翔英, 梅芳, 邓旭亮, 曹采方. 多孔β-磷酸三钙/胶原支架与犬牙周膜细胞三维复合体的构建[J]. 北京大学学报(医学版), 2007, 39(5): 507 -510 .
[3] 刘朝晖, 吴文湘, 廖秦平. 体外培养人阴道上皮细胞感染假性酵母菌后肿瘤坏死因子-α的表达改变[J]. 北京大学学报(医学版), 2007, 39(5): 539 -541 .
[4] 崔国辉, 沈琳, 张蕾, 侯新朴. 血卟啉衍生物脂质体瘤内注射给药在荷瘤鼠体组织中的药物分布[J]. 北京大学学报(医学版), 2001, 33(3): 255 -257 .
[5] 季成叶. 中国青少年生长与营养状况变化和改善策略[J]. 北京大学学报(医学版), 2002, 34(5): 525 -529 .
[6] 吴薇, 陈敏华, 付颖, 张仲一, 杨薇, 严昆. 446例肝细胞癌射频消融治疗远期疗效[J]. 北京大学学报(医学版), 2010, 42(6): 716 -721 .
[7] 贾军, 任军, 张红梅, 张利旺, 郭晓彤. 造血干细胞来源的树突状细胞负载p53基因诱导对HMCC97肝癌细胞特异性杀伤[J]. 北京大学学报(医学版), 2008, 40(5): 489 -493 .
[8] 倪永伟, 周永胜, 刘云松, 曾百进, 许永伟. 人、兔、大鼠脂肪基质细胞的生物学性状对比[J]. 北京大学学报(医学版), 2009, 41(1): 95 -99 .
[9] 王玢, 罗非, 葛学彩, 付爱华, 韩济生. 6-羟多巴胺损毁中脑边缘多巴胺能系统抑制药物点燃诱导的大鼠吗啡条件性位置偏爱消退后重建[J]. 北京大学学报(医学版), 2003, 35(5): 449 -452 .
[10] 李楠, 马靖, 聂立功, 李海潮, 阙呈立, 高志东, 王广发, 徐小元, 陆海英, 王贵强. 肾上腺糖皮质激素治疗SARS的回顾性分析[J]. 北京大学学报(医学版), 2003, 35(z1): 16 -18 .